These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 25426963)
1. Advancements in the development of HIF-1α-activated protein switches for use in enzyme prodrug therapy. Wright RC; Khakhar A; Eshleman JR; Ostermeier M PLoS One; 2014; 9(11):e114032. PubMed ID: 25426963 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-Activated Prodrug Enabling Synchronous Chemotherapy and HIF-1α Downregulation for Tumor Treatment. Luo X; Li A; Chi X; Lin Y; Liu X; Zhang L; Su X; Yin Z; Lin H; Gao J Bioconjug Chem; 2021 May; 32(5):983-990. PubMed ID: 33847488 [TBL] [Abstract][Full Text] [Related]
3. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221. Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897 [TBL] [Abstract][Full Text] [Related]
4. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314 [TBL] [Abstract][Full Text] [Related]
6. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310 [TBL] [Abstract][Full Text] [Related]
7. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
8. Protein-Programmed Accumulation of Yeast Cytosine Deaminase in Cancer Cells in Response to Mock-Hypoxia. Warren TD; Patel K; Eshleman JR; Ostermeier M ACS Synth Biol; 2019 May; 8(5):948-954. PubMed ID: 30998310 [TBL] [Abstract][Full Text] [Related]
9. The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil. Gariboldi MB; Taiana E; Bonzi MC; Craparotta I; Giovannardi S; Mancini M; Monti E Cancer Lett; 2015 Aug; 364(2):156-64. PubMed ID: 25979228 [TBL] [Abstract][Full Text] [Related]
10. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy. Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801 [TBL] [Abstract][Full Text] [Related]
11. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001 [TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone inhibits HIF-1α expression in a topoisomerase II-independent pathway. Toh YM; Li TK Clin Cancer Res; 2011 Aug; 17(15):5026-37. PubMed ID: 21653687 [TBL] [Abstract][Full Text] [Related]
14. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269 [TBL] [Abstract][Full Text] [Related]
15. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells. Bai H; Ge S; Lu J; Qian G; Xu R J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional upregulation of MT2-MMP in response to hypoxia is promoted by HIF-1α in cancer cells. Zhu S; Zhou Y; Wang L; Zhang J; Wu H; Xiong J; Zhang J; Tian Y; Wang C; Wu H Mol Carcinog; 2011 Oct; 50(10):770-80. PubMed ID: 21751260 [TBL] [Abstract][Full Text] [Related]
18. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells. Alqawi O; Moghaddas M; Singh G Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534 [TBL] [Abstract][Full Text] [Related]
19. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor. Lee K; Kim HM Arch Pharm Res; 2011 Oct; 34(10):1583-5. PubMed ID: 22076756 [TBL] [Abstract][Full Text] [Related]
20. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]